This federal contract award, valued at $1,057.09, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The current delivery order is for the supply of Micardis HCT 80-12.5 mg tablets, a medication used to treat hypertension. The contract does not have a set-aside designation, indicating open competition. This award demonstrates AmerisourceBergen's extensive role in supplying essential pharmaceuticals and medical commodities to federal government agencies, particularly the Department of Defense and its healthcare programs.
Generated 2/27/25, 11:19 AM